Here are some highlights from the first half of the year: ...

Curry is the CEO of Thirty Ink, which generated $174 million in revenue last year, and all of its business units are ...

DOUGLASSVILLE, PA — American Crane & Equipment Corporation (ACECO) has completed a meaningful new addition to its corporate ...

a pre-commercial stage biopharmaceutical company, announces that three abstracts have been accepted for poster presentations at the upcoming Association for Research in Vision and Ophthalmology ...

--(BUSINESS WIRE)--Sydnexis, Inc., (www.sydnexis.com) a pre-commercial stage biopharmaceutical company, announces that three abstracts have been accepted for poster presentations at the upcoming ...

A fan-made poster imagining 'Animal 2' is creating buzz ... hinting that only the original director can do justice to such an intense vision. High expectations for the sequel starring Ranbir ...

today announced that the Company will give two poster presentations at the Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting being held May 4–8, 2025, in Salt Lake City, Utah.

today announced that the Company will give two poster presentations at the Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting being held May 4–8, 2025, in Salt Lake City ...

Tinlarebant is a novel oral therapy that is intended to reduce the accumulation of vitamin A-based toxins (known as bisretinoids) that cause retinal disease in Stargardt Disease type 1 (STGD1) and ...